BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy

NCT07755904 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiomyopathy, Hypertrophic Obstructive

Interventions

DRUG: BHB-1893
DRUG: Metoprolol

Sponsor

Braveheart Bio, Inc.